TELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation

Reuters01-08

TELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation

TELUS Corporation has engaged TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to support the monetisation strategy for its TELUS Health business. The advisors will assist in identifying and evaluating potential strategic partnerships to help accelerate TELUS Health’s growth and international expansion. TELUS Health currently serves more than 160 million lives in over 200 countries and territories, with year-to-date operating revenue of $1.5 billion, EBITDA of $258 million, and cash flow of $99 million as of the third quarter of 2025. The move is part of TELUS' broader strategy to enhance value creation, scale, and growth for TELUS Health by bringing in a partner with complementary capabilities and reach.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELUS Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: MO59066) on January 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2601365703?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-08 19:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601365703","market":"us","top_or_hot":-1,"title":"TELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      TELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        TELUS Corporation has engaged TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to support the monetisation strategy for its TELUS Health business. The advisors will assist in identifying and evaluating potential strategic partnerships to help accelerate TELUS Health’s growth and international expansion. TELUS Health currently serves more than 160 million lives in over 200 countries and territories, with year-to-date operating revenue of $1.5 billion, EBITDA of $258 million, and cash flow of $99 million as of the third quarter of 2025. The move is part of TELUS' broader strategy to enhance value creation, scale, and growth for TELUS Health by bringing in a partner with complementary capabilities and reach.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELUS Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: MO59066) on January 08, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-08 19:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      TELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        TELUS Corporation has engaged TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to support the monetisation strategy for its TELUS Health business. The advisors will assist in identifying and evaluating potential strategic partnerships to help accelerate TELUS Health’s growth and international expansion. TELUS Health currently serves more than 160 million lives in over 200 countries and territories, with year-to-date operating revenue of $1.5 billion, EBITDA of $258 million, and cash flow of $99 million as of the third quarter of 2025. The move is part of TELUS' broader strategy to enhance value creation, scale, and growth for TELUS Health by bringing in a partner with complementary capabilities and reach.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELUS Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: MO59066) on January 08, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JEF","symbol_name":"杰富瑞","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL9Zwp7V:1","article_id":"2601365703","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601365703","pubTimestamp":1767872720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"TELUS Corporation has engaged TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to support the monetisation strategy for its TELUS Health business. The advisors will assist in identifying and evaluating potential strategic partnerships to help accelerate TELUS Health’s growth and international expansion. TELUS Health currently serves more than 160 million lives in over 200 countries and territories, with year-to-date operating revenue of $1.5 billion, EBITDA of $258 million, and cash flow of $99 million as of the third quarter of 2025. The move is part of TELUS' broader strategy to enhance value creation, scale, and growth for TELUS Health by bringing in a partner with complementary capabilities and reach.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JEF":"杰富瑞","BK4559":"巴菲特持仓","BK4127":"投资银行业与经纪业"},"translate_title":"TELUS与道明证券和杰富瑞合作探索TELUS Health货币化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JEF":0.9},"content_text":"TELUS Engages TD Securities and Jefferies to Explore TELUS Health Monetisation\n    \n\n        TELUS Corporation has engaged TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to support the monetisation strategy for its TELUS Health business. The advisors will assist in identifying and evaluating potential strategic partnerships to help accelerate TELUS Health’s growth and international expansion. TELUS Health currently serves more than 160 million lives in over 200 countries and territories, with year-to-date operating revenue of $1.5 billion, EBITDA of $258 million, and cash flow of $99 million as of the third quarter of 2025. The move is part of TELUS' broader strategy to enhance value creation, scale, and growth for TELUS Health by bringing in a partner with complementary capabilities and reach.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELUS Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: MO59066) on January 08, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601365703","isCrawlerRequest":true}